HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
October 31, 2025 08:00 ET | Source: HOOKIPA Pharma Inc. NEW YORK…
Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop
– Phase 1a clinical data in healthy participants presented for both ABI-5366…
